» Articles » PMID: 16861608

Neural Mechanisms Underlying Hyperphagia in Prader-Willi Syndrome

Overview
Date 2006 Jul 25
PMID 16861608
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Prader-Willi syndrome (PWS) is a genetic disorder associated with developmental delay, obesity, and obsessive behavior related to food consumption. The most striking symptom of PWS is hyperphagia; as such, PWS may provide important insights into factors leading to overeating and obesity in the general population. We used functional magnetic resonance imaging to study the neural mechanisms underlying responses to visual food stimuli, before and after eating, in individuals with PWS and a healthy weight control (HWC) group.

Research Methods And Procedures: Participants were scanned once before (pre-meal) and once after (post-meal) eating a standardized meal. Pictures of food, animals, and blurred control images were presented in a block design format during acquisition of functional magnetic resonance imaging data.

Results: Statistical contrasts in the HWC group showed greater activation to food pictures in the pre-meal condition compared with the post-meal condition in the amygdala, orbitofrontal cortex, medial prefrontal cortex (medial PFC), and frontal operculum. In comparison, the PWS group exhibited greater activation to food pictures in the post-meal condition compared with the pre-meal condition in the orbitofrontal cortex, medial PFC, insula, hippocampus, and parahippocampal gyrus. Between-group contrasts in the pre- and post-meal conditions confirmed group differences, with the PWS group showing greater activation than the HWC group after the meal in food motivation networks.

Discussion: Results point to distinct neural mechanisms associated with hyperphagia in PWS. After eating a meal, the PWS group showed hyperfunction in limbic and paralimbic regions that drive eating behavior (e.g., the amygdala) and in regions that suppress food intake (e.g., the medial PFC).

Citing Articles

Case report: Long-term efficacy and safety of semaglutide in the treatment of syndromic obesity in Prader Willi syndrome - case series and literature review.

Koceva A, Mlekus Kozamernik K, Janez A, Herman R, Ferjan S, Jensterle M Front Endocrinol (Lausanne). 2025; 15:1528457.

PMID: 39906041 PMC: 11790462. DOI: 10.3389/fendo.2024.1528457.


Defining Hyperphagia for Improved Diagnosis and Management of MC4R Pathway-Associated Disease: A Roundtable Summary.

Heymsfield S, Clement K, Dubern B, Goldstone A, Haqq A, Kuhnen P Curr Obes Rep. 2025; 14(1):13.

PMID: 39856371 PMC: 11762201. DOI: 10.1007/s13679-024-00601-z.


Prolonged latency of the gustatory evoked potentials for sucrose solution in subjects living with obesity compared with normal-weight subjects.

Mouillot T, Brindisi M, Gauthier C, Barthet S, Quere C, Litime D Int J Obes (Lond). 2024; 48(12):1720-1727.

PMID: 39183345 DOI: 10.1038/s41366-024-01607-2.


Microglial phagolysosome dysfunction and altered neural communication amplify phenotypic severity in Prader-Willi Syndrome with larger deletion.

Correa-da-Silva F, Carter J, Wang X, Sun R, Pathak E, Kuhn J Acta Neuropathol. 2024; 147(1):64.

PMID: 38556574 PMC: 10982101. DOI: 10.1007/s00401-024-02714-0.


Hypothalamic volume is associated with body mass index.

Brown S, Westwater M, Seidlitz J, Ziauddeen H, Fletcher P Neuroimage Clin. 2023; 39:103478.

PMID: 37558541 PMC: 10509524. DOI: 10.1016/j.nicl.2023.103478.


References
1.
Shapira N, Lessig M, He A, James G, Driscoll D, Liu Y . Satiety dysfunction in Prader-Willi syndrome demonstrated by fMRI. J Neurol Neurosurg Psychiatry. 2005; 76(2):260-2. PMC: 1739487. DOI: 10.1136/jnnp.2004.039024. View

2.
Nevsimalova S, Vankova J, Stepanova I, Seemanova E, Mignot E, Nishino S . Hypocretin deficiency in Prader-Willi syndrome. Eur J Neurol. 2004; 12(1):70-2. DOI: 10.1111/j.1468-1331.2004.00969.x. View

3.
Talebizadeh Z, Kibiryeva N, Bittel D, Butler M . Ghrelin, peptide YY and their receptors: gene expression in brain from subjects with and without Prader-Willi syndrome. Int J Mol Med. 2005; 15(4):707-11. PMC: 5459610. View

4.
Risinger R, Salmeron B, Ross T, Amen S, Sanfilipo M, Hoffmann R . Neural correlates of high and craving during cocaine self-administration using BOLD fMRI. Neuroimage. 2005; 26(4):1097-108. DOI: 10.1016/j.neuroimage.2005.03.030. View

5.
Holsen L, Zarcone J, Thompson T, Brooks W, Anderson M, Ahluwalia J . Neural mechanisms underlying food motivation in children and adolescents. Neuroimage. 2005; 27(3):669-76. PMC: 1535274. DOI: 10.1016/j.neuroimage.2005.04.043. View